Combination of chemotherapy and Au-nanoparticle photothermy in the visible light to tackle doxorubicin resistance in cancer cells

This work was supported by the Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO which is financed by national funds from FCT/MEC (UID/Multi/04378/2013; UID/QUI/00100/2013) and co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728); PP for PD/BD/105734/2014; R...

ver descrição completa

Detalhes bibliográficos
Autor principal: Pedrosa, Pedro (author)
Outros Autores: Mendes, Rita (author), Cabral, Rita (author), Martins, Luísa M. D. R. S. (author), Baptista, Pedro V. (author), Fernandes, Alexandra R. (author)
Formato: article
Idioma:eng
Publicado em: 2019
Assuntos:
Infrared devices
Chemotherapy
Therapy PTT
General
SDG 3 - Good Health and Well-being
Texto completo:https://doi.org/10.1038/s41598-018-29870-0
País:Portugal
Oai:oai:run.unl.pt:10362/58652
Descrição
Resumo:This work was supported by the Unidade de Ciencias Biomoleculares Aplicadas - UCIBIO which is financed by national funds from FCT/MEC (UID/Multi/04378/2013; UID/QUI/00100/2013) and co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728); PP for PD/BD/105734/2014; RM for SFRH/BD/132163/2017. I. Coutinho for access to laser and P. Martins for initial induction of HCT116 DOXR.

Registros relacionados